Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Japan Drug Makers Derive Near-60% of FY2020 Sales Overseas as Home Market Falters: Tally
June 8, 2021
- FDA Approves Aducanumab, 1st Disease-Modifying Therapy for Alzheimer’s
June 8, 2021
- Japan Ethical Drug Sales Down 2.4% in April: Crecon
June 8, 2021
- Keytruda Retrieves Top-Selling Crown in Japan in May: Encise
June 8, 2021
- Daiichi Sankyo’s ADC U3-1402 Scores 39% ORR for EGFR-Mutated NSCLC in PI
June 8, 2021
- Bristol Myers, Other Pharma Players Moving to Join Workplace Vaccination Campaign
June 7, 2021
- Kobayashi Kako’s 116-Day Suspension Over, but No Timeline for Resumption
June 7, 2021
- Reps’ Face-to-Face Meetings Up 60% YOY in April, but Fall Shy of Prepandemic Level: Intage
June 7, 2021
- AstraZeneca Launches Exploratory Study to Predict Onset of ILD in NSCLC Patients on Imfinzi
June 7, 2021
- MSD Japan Spins Off Organon Women’s Health Biz, Ryota Sakurai Takes Helm
June 4, 2021
- Aspen Japan to Be Renamed Sandoz Pharma in September
June 4, 2021
- Astellas Plans to Cut 450 Jobs via Voluntary Redundancy Program
June 4, 2021
- Keio Upstart, Novo Nordisk Ink Global Deal on iPSC-Based Heart Therapy
June 2, 2021
- Amgen Gets Rights to Kyowa Kirin’s Atopic Dermatitis Drug
June 2, 2021
- Incyte’s Debuts Its 1st Product in Japan; Mitsubishi’s Uplizna Now Available Too
June 2, 2021
- FDA Target Date for Vadadustat Set for March 29: Otsuka/Akebia
June 2, 2021
- Shionogi, Chiyoda Eye JV for Continuous Manufacturing of APIs, Intermediates
June 2, 2021
- SGLT2 Inhibitors Again Poised for Double-Digit Growth in FY2021; Forxiga Overtakes Jardiance in April
June 1, 2021
- 52 More Nichi-Iko Products Face Supply Stoppage as Risk Assessment Continues
June 1, 2021
- Jail Terms Sought for 2 Ono Employees over Onoact-Tied Bribery Charges
June 1, 2021
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…